Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): A cross-sectional study

The Lancet Global Health

Volumn 4, Issue 5, 2016, Pages e307-e319

  Ene Iordache, Bogdan ^a   Perico, Norberto ^a   Bikbov, Boris ^b,c   Carminati, Sergio ^a   Remuzzi, Andrea ^a,d   Perna, Annalisa ^a   Islam, Nazmul ^e   Bravo, Rodolfo Flores ^f   Aleckovic Halilovic, Mirna ^g   Zou, Hequn ^h   Zhang, Luxia ⁱ   Gouda, Zaghloul ^j   Tchokhonelidze, Irma ^k   Abraham, Georgi ^l   Mahdavi Mazdeh, Mitra ^m   Gallieni, Maurizio ⁿ   Codreanu, Igor ^o   Togtokh, Ariunaa ^p   Sharma, Sanjib Kumar ^q   Koirala, Puru ^q   Uprety, Samyog ^q   Ulasi, Ifeoma ^r   Remuzzi, Giuseppe ^a,n,s   more..

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b A I EVDOKIMOV MOSCOW STATE UNIVERSITY OF MEDICINE AND DENTISTRY   (Russian Federation)

^c SHUMAKOV NATIONAL MEDICAL RESEARCH CENTER OF TRANSPLANTOLOGY AND ARTIFICIAL ORGANS   (Russian Federation)

^d UNIVERSITY OF BERGAMO   (Italy)

^e Department of Nephrology   (Bangladesh)

^f Hospital Juan XXIII   (Bolivia)

^g UNIVERSITY CLINICAL CENTER TUZLA   (Bosnia and Herzegovina)

^h THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

ⁱ PEKING UNIVERSITY FIRST HOSPITAL   (China)

^j General Organization of Teaching Hospitals and Institutes   (Egypt)

^k TBILISI STATE MEDICAL UNIVERSITY   (Georgia)

^l Tamilnad Kidney Research Foundation   (India)

^m TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

ⁿ UNIVERSITY OF MILAN   (Italy)

^o Ministry of Health Transplant Agency   (Moldova)

^p University of Mongolia   (Mongolia)

^q B P KOIRALA INSTITUTE OF HEALTH SCIENCES   (Nepal)

^r UNIVERSITY OF NIGERIA   (Nigeria)

^s Azienda Ospedaliera Papa Giovanni XXIII   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BANGLADESH; BOLIVIA; BOSNIA AND HERZEGOVINA; CARDIOVASCULAR RISK; CHINA; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; EGYPT; FEMALE; FRAMINGHAM RISK SCORE; GEORGIA (REPUBLIC); HIGH RISK POPULATION; HUMAN; HYPERTENSION; INDIA; IRAN; MALE; MASS SCREENING; MOLDOVA; MONGOLIA; NEPAL; NIGERIA; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; AGED; ATTITUDE TO HEALTH; AWARENESS; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; AWARENESS; BANGLADESH; BOLIVIA; BOSNIA AND HERZEGOVINA; CARDIOVASCULAR DISEASES; CHINA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; EGYPT; FEMALE; GEORGIA (REPUBLIC); HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; INDIA; IRAN; MALE; MASS SCREENING; MIDDLE AGED; MOLDOVA; MONGOLIA; NEPAL; NIGERIA; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84963742741     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(16)00071-1     Document Type: Article

References (53)

1. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 385:117-171. GBD 2013 Mortality and Causes of Death Collaborators.
2. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 386:743-800. Global Burden of Disease Study 2013 Collaborators.
3. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013, 3:1-150. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group.
4. White SL, Chadban SJ, Jan S, Chapman JR, Cass A How can we achieve global equity in provision of renal replacement therapy?. Bull World Health Organ 2008, 86:229-237.
5. Couser WG, Remuzzi G, Mendis S, Tonelli M The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 2011, 80:1258-1270.
6. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003, 41:1-12.
7. Hallan SI, Coresh J, Astor BC, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006, 17:2275-2284.
8. Hillege HL, Janssen WM, Bak AA, et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 2001, 249:519-526.
9. Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 2003, 14(7 suppl 2):S131-S138.
10. Stanifer JW, Jing B, Tolan S, et al. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health 2014, 2:e174-e181.
11. Rosenberg AZ, Naicker S, Winkler CA, Kopp JB HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment. Nat Rev Nephrol 2015, 11:150-160.
12. Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013, 382:260-272.
13. Correa-Rotter R, Wesseling C, Johnson RJ CKD of unknown origin in Central America: the case for a Mesoamerican nephropathy. Am J Kidney Dis 2014, 63:506-520.
14. Clinical research program International Society of Nephrology, (accessed Nov 11, 2015). http://www.theisn.org/programs/clinical-research-program.
15. Sharma SK, Zou H, Togtokh A, et al. Burden of CKD, proteinuria, and cardiovascular risk among Chinese, Mongolian, and Nepalese participants in the International Society of Nephrology screening programs. Am J Kidney Dis 2010, 56:915-927.
16. Gallieni M, Ene-Iordache B, Aiello A, et al. Hypertension and kidney function in an adult population of West Bengal, India: Role of body weight, waist circumference, proteinuria and rural area living. Nephrology (Carlton) 2013, 18:798-807.
17. Codreanu I, Sali V, Gaibu S, et al. Prevalence of hypertension and diabetes and coexistence of chronic kidney disease and cardiovascular risk in the population of the Republic of Moldova. Int J Hypertens 2012, 2012:951734.
18. Cravedi P, Sharma SK, Bravo RF, et al. Preventing renal and cardiovascular risk by renal function assessment: insights from a cross-sectional study in low-income countries and the USA. BMJ Open 2012, 2:e001357.
19. Mahdavi-Mazdeh M, Saeed Hashemi Nazri S, Hajghasemi E, Nozari B, Zinat Nadia H, Mahdavi A Screening for decreased renal function in taxi drivers in Tehran, Iran. Ren Fail 2010, 32:62-68.
20. Gouda Z, Mashaal G, Bello AK, et al. Egypt Information, Prevention, and Treatment of Chronic Kidney Disease (EGIPT-CKD) programme: prevalence and risk factors for microalbuminuria among the relatives of patients with CKD in Egypt. Saudi J Kidney Dis Transpl 2011, 22:1055-1063.
21. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
22. Wen CP, Matsushita K, Coresh J, et al. Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar. Kidney Int 2014, 86:819-827.
23. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2572. the National High Blood Pressure Education Program Coordinating Committee.
24. Obesity: preventing and managing the global epidemic 2000, WHO, World Health Organization, Geneva.
25. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363:157-163. WHO Expert Consultation.
26. D'Agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117:743-753.
27. Cooney MT, Dudina A, D'Agostino R, Graham IM Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future?. Circulation 2010, 122:300-310.
28. Selvarajah S, Kaur G, Haniff J, et al. Comparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian population. Int J Cardiol 2014, 176:211-218.
29. Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 2012, 379:815-822.
30. Freedman BI, Divers J, Palmer ND Population ancestry and genetic risk for diabetes and kidney, cardiovascular, and bone disease: modifiable environmental factors may produce the cures. Am J Kidney Dis 2013, 62:1165-1175.
31. Vassalotti JA, Fox CH, Becker BN Risk factors and screening for chronic kidney disease. Adv Chronic Kidney Dis 2010, 17:237-245.
32. Manns B, Hemmelgarn B, Tonelli M, et al. Population based screening for chronic kidney disease: cost effectiveness study. BMJ 2010, 341:c5869.
33. Fink HA, Ishani A, Taylor BC, et al. Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U S Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Ann Intern Med 2012, 156:570-581.
34. Kessler R, Keusch G, Szucs TD, et al. Health economic modelling of the cost-effectiveness of microalbuminuria screening in Switzerland. Swiss Med Wkly 2012, 142:w13508.
35. de Lima AO, Kesrouani S, Gomes RA, Cruz J, Mastroianni-Kirsztajn G Population screening for chronic kidney disease: a survey involving 38,721 Brazilians. Nephrol Dial Transplant 2012, 27(suppl 3):iii135-iii138.
36. Anand S, Shivashankar R, Ali MK, et al. Prevalence of chronic kidney disease in two major Indian cities and projections for associated cardiovascular disease. Kidney Int 2015, 88:178-185.
37. Vassalotti JA, Li S, Chen SC, Collins AJ Screening populations at increased risk of CKD: the Kidney Early Evaluation Program (KEEP) and the public health problem. Am J Kidney Dis 2009, 53(3 suppl 3):S107-S114.
38. Whaley-Connell A, Shlipak MG, Inker LA, et al. Awareness of kidney disease and relationship to end-stage renal disease and mortality. Am J Med 2012, 125:661-669.
39. Shah A, Fried LF, Chen SC, et al. Associations between access to care and awareness of CKD. Am J Kidney Dis 2012, 59(3 suppl 2):S16-S23.
40. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003, 108:2154-2169.
41. Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary-Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2007, 28:2375-2414.
42. Orth SR Smoking and the kidney. J Am Soc Nephrol 2002, 13:1663-1672.
43. Stangenberg S, Chen H, Wong MG, Pollock CA, Saad S Fetal programming of chronic kidney disease: the role of maternal smoking, mitochondrial dysfunction, and epigenetic modfification. Am J Physiol Renal Physiol 2015, 308:F1189-F1196.
44. Stevens LA, Claybon MA, Schmid CH, et al. Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int 2011, 79:555-562.
45. Jaar BG, Khatib R, Plantinga L, Boulware LE, Powe NR Principles of screening for chronic kidney disease. Clin J Am Soc Nephrol 2008, 3:601-609.
46. Brück K, Jager KJ, Dounousi E, et al. Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review. Nephrol Dial Transplant 2015, 30(suppl 4):iv6-i16.
47. Brück K, Stel VS, Gambaro G, et al. CKD prevalence varies across the European general population. J Am Soc Nephrol 2015, on behalf of the European CKD Burden Consortium, published online Dec 23. 10.1681/ASN.2015050542.
48. Aitken GR, Roderick PJ, Fraser S, et al. Change in prevalence of chronic kidney disease in England over time: comparison of nationally representative cross-sectional surveys from 2003 to 2010. BMJ Open 2014, 4:e005480.
49. CKD analytic methods. In: 2015 annual data report: vol 1, chronic kidney disease (CKD) in the United States 2015, United States Renal Data System, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda.
50. Teo BW, Xu H, Wang D, et al. GFR estimating equations in a multiethnic Asian population. Am J Kidney Dis 2011, 58:56-63.
51. Jessani S, Levey AS, Bux R, et al. Estimation of GFR in South Asians: a study from the general population in Pakistan. Am J Kidney Dis 2014, 63:49-58.
52. Delanaye P, Mariat C The applicability of eGFR equations to different populations. Nat Rev Nephrol 2013, 9:513-522.
53. Kong X, Ma Y, Chen J, et al. Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating glomerular filtration rate in the Chinese population. Nephrol Dial Transplant 2013, 28:641-651.